RUNX1 has been shown to promote the efficient growth of AML cells including t(8;21) AML, but a previous study reported that RUNX1 promotes the tumor growth only in tumors with intact TP53 [19]. This evidence concerns the gene TP53 and acute myeloid leukemia.